FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
This article was originally published in The Gray Sheet
Executive Summary
Over-the-counter (OTC) HIV test kits would answer an unmet need, but clinical trials and product labeling must be carefully crafted to ensure that benefits outweigh the risks, according to FDA's Blood Products Advisory Committee